Clinical trial

Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on…

NCT00253929 · Radboud University Medical Center, Other · Completed

Key facts

NCT number NCT00253929
Title Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia
Official title The Influence of the 1976T>C Polymorphism in the Adenosine A2A Receptor Gene on Adenosine-Induced Vasodilation and the Influence of the 34C>T Polymorphism in the AMP Deaminase Gene on Post-Occlusive Reactive Hyperemia.
Lead sponsor Radboud University Medical Center, Other
Collaborators ZonMw: The Netherlands Organisation for Health Research and Development
Status Completed
Study type Interventional
Conditions Blood Flow in Healthy Volunteers
Intervention type Drug, Procedure
Interventions Intra-arterial infusion of adenosine, intra-arterial infusion of caffeine, intra-arterial infusion of acetylcholine, intra-arterial infusion of sodium nitroprusside, Occlusion of arm-circulation by inflation of upper-arm cuff to 200mmHg for 2, 5 and 13 minutes
Enrollment 100
Start date Nov 1, 2005
Completion Feb 1, 2006
First posted Nov 15, 2005
Last update posted Apr 5, 2007
Countries Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies